FOSL1 and breast neoplasm: By stabilizing Fra-1 expression, PRKCQ can also stimulate the migration of TNBC cells while promoting the epithelial-mesenchymal transition in these breast tumor cells through the phosphorylation and activation of LSD1, thus supporting breast cancer growth and dissemination (27).